Long Covid, The Spike Protein, Vaccine Effects and Clinical Approach

One of you shared the following article with me from the Journal of American Physicians and Surgeons:

Clinical Rationale for SARS-CoV-2 Base Spike Protein
Detoxification in Post COVID-19 and Vaccine
Injury Syndromes

It makes for very sober reading, but at least give some rationales for offsetting the vaccine injury.

As the authors say: in normal infection and people with good immunity, the Covid virus is handled well by mucosal immunity (those of you with low SIgA take note – low mucosal immunity!) and all is well.

We produce IgG antibodies to the virus spike protein, which is a natural and important part of our immune response to deal with it. However, as the authors explain, the immune response after the vaccine was much stronger and, left uncontrolled (low regulatory T cells possibly – see low SCFAs on gut results?) could well explain persistent Long Covid symptoms and injury after vaccines in some people.

They explain:

The rise
in IgG against the spike protein is many fold greater after
vaccination than from the natural infection. This is a proxy
for considerably greater exposure to the spike protein after
immunization than after infection. Anti-spike IgG levels are
associated with post-COVID-19 symptoms.3
Yonker et al.
have recently shown that some individuals do not develop
neutralizing antibodies against the spike protein, and as
a result develop organ injury, particularly myocarditis in
children and young adults.4
Free circulating soluble and
extracellular vesicle-linked spike protein is associated with
persistent symptoms.5

The spike protein……drives the development
of adverse events, injuries, disabilities, and death after
vaccination through immunologic and thrombotic
mechanisms. The spike protein has been found in the brain,
heart, liver, kidneys, ovaries, testicles and other vital organs
at autopsy in cases of death after vaccination.6-9 In the case
of vaccine-induced thrombotic injury, the spike protein has
been found within the blood clot itself.10

Read the full article here

Thankfully, they go on to offer clinical approaches for helping to degrade any residual spike protein and lowering its effect on organs and tissues. These include enzymes and anti-inflammatories such as nattokinase, bromelain and curcumin. As they admit, there are lots of compounds that could actually help including NAC, glutathione, selenium, nigella and more. They detail dosage amounts of the key ‘triad’ of supplements, as they see it, in the article. They also caution the use of these in people with poor clotting as it could increase bleeding.

… the triad of nattokinase 2,000 FU (100 mg) twice daily,
bromelain 500 mg a day, and nano-curcumin 500 mg twice
daily for at least 3 months with continuation for a year or
more, as a base detoxification regimen upon which additional
agents can be added, is a reasonable empiric strategy for those
suffering with post COVID-19 or vaccine-associated symptoms.
Clinicians should recognize this combination has significant
anticoagulant effects that will be potentially counterbalanced
by the pro-coagulant effects of spike protein.

Consider these type of supplements:

Nattokinase and Bromelain

A very absorbable curcumin (not nano, but I’m not sure about nano supplements myself yet).

Personally, I would add lauric acid to help break down any residual virus itself – as I explain in my Covid Factsheet.

It is a bit galling that many of us have been advising this sort of approach for long Covid for a good while now, but it is excellent to see it in a prestigious mainstream journal – although I do note some conflict of interests in one of the authors being involved in nattokinase supplements! Even so, let’s hope the message will get through now and start really helping people?

Meantime, I’ll pop a link to this in the Long Covid section of the factsheet for you. Please do share if you know anyone it could help.

Please support Purehealth

Leave a Reply

Discover more from Purehealth Clinic

Subscribe now to keep reading and get access to the full archive.

Continue reading